Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

bispecific T-cell engager

(BY-speh-SIH-fik … en-GAY-jer)
A substance made in the laboratory that can bind to two target proteins on the surface of different cells. For example, a bispecific T-cell engager may bind to a certain protein on healthy T cells (a type of immune cell) and, at the same time, to a different protein on cancer cells. This brings the T cells and cancer cells close together so the T cells can more effectively kill the cancer cells. Some bispecific T-cell engagers are being used to treat certain types of cancer, including acute lymphoblastic leukemia, multiple myeloma, lymphoma, and small cell lung cancer. They are a type of targeted therapy. Also called BiTE.
Search NCI's Dictionary of Cancer Terms